Author: David Palacios Rubio

What new rules lie ahead for tobacco alternatives on the road through 2021?

Written by David Palacios Rubio || 7th January 2021 || Regulatory briefing |

Asia
Brazil
China
Denmark
EU
Europe
Ireland
Netherlands
North America
Norway
Philippines
Russia
South America
South Korea
Sweden
Switzerland
UK
Ukraine
United States
World
Heated tobacco
Politics & policy
Regulation and Legislation
Snus and oral
Regulatory briefing
The new year looks certain to become another significant one for the tobacco-alternatives industry across the globe, with a bunch of new regulations on the horizon ...

UK tobacco regulation review likely after Brexit deal signed

Written by David Palacios Rubio || 24th December 2020 || Business briefing |

EU
Europe
UK
Politics & policy
Regulation and Legislation
Business briefing
After the eleventh-hour agreement of a Brexit deal on Christmas Eve, one of the first key issues for the go-it-alone UK to tackle will be the review of the Tobacco and Related Products Regulations (TRPR) ...

EU Parliament endorses Commission’s new health programme

Written by David Palacios Rubio || 13th November 2020 || Regulatory briefing |

EU
EU
Europe
Regulation and Legislation
Regulatory briefing
The European Parliament approved by an overwhelming majority the EU health policy programme for the period 2021-2017 aimed at tackling some of the main health issues in Europe, including tobacco policy ...

Deadline, 4pm Wednesday – time’s almost up for US PMTAs

Written by David Palacios Rubio || 7th September 2020 || Regulatory briefing |

North America
United States
Politics & policy
Regulatory briefing
The final countdown is on to Wednesday's deadline for premarket tobacco product applications (PMTAs), which the US Food and Drug Administration (FDA) officially set at 4pm Eastern Time (ET) on 9th September ...

BAT’s modern oral portfolio increases 74% in a year

Written by David Palacios Rubio || 31st July 2020 || Business briefing |

Europe
North America
UK
United States
Companies
Heated tobacco
Snus and oral
Business briefing
BAT’s revenue from its smokeless portfolio increased by 5.7% to £9.4bn ($12.3bn) in the first six months of the year, helped by higher revenue in the modern oral segment ...

US FDA prepares to extend PMTA deadline – if court agrees to it

Written by David Palacios Rubio || 31st March 2020 || Regulatory briefing |

North America
United States
Heated tobacco
Politics & policy
Regulatory briefing
The US Food and Drug Administration (FDA) has requested a 120-day extension to the deadline for premarket tobacco product applications (PMTAs) due to the challenges that the coronavirus outbreak is posing to companies ...

BAT reports 273% revenue increase in a year for its modern oral portfolio

Written by David Palacios Rubio || 28th February 2020 || Business briefing |

Asia
Denmark
Europe
Japan
North America
Norway
Russia
Sweden
Switzerland
UK
Ukraine
United States
World
Companies
Heated tobacco
Snus and oral
Business briefing
British American Tobacco (BAT)'s "modern oral" portfolio has been one of the main drivers helping the company achieve good results in 2019 for its next-generation products category, which overall increased globally by 36.9% ...